Narrow-leafed lupin (Lupinus angustifolius L.) ß-conglutin proteins modulate the insulin signaling pathway as potential type 2 diabetes treatment and inflammatory-related disease amelioration
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.Scope: We have investigated the potential use of ß-conglutin protein isoforms from narrow-leafed lupin (Lupinus angustifolius L.) as a diabetes treatment. Methods and results: We produced purified recombinant ß1-, ß2-, ß3-, ß4-, and ß6-conglutin...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Wiley - V C H Verlag GmbH
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/48975 |